{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:33:29Z","timestamp":1760852009638},"reference-count":41,"publisher":"American Society for Microbiology","issue":"7","license":[{"start":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2003,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Monotherapy of hepatitis C virus infection with either alpha interferon or ribavirin alone is rather ineffective, while the use of the two antivirals together is much more efficacious. In vitro drug-drug combination analysis utilizing related members of the family\n            <jats:italic>Flaviviridae<\/jats:italic>\n            , bovine viral diarrhea virus and yellow fever virus, revealed significant direct synergistic interactions between these drugs' antiviral activities that might explain this clinical observation.\n          <\/jats:p>","DOI":"10.1128\/aac.47.7.2293-2298.2003","type":"journal-article","created":{"date-parts":[[2003,6,23]],"date-time":"2003-06-23T19:17:06Z","timestamp":1056395826000},"page":"2293-2298","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":41,"title":["Synergistic In Vitro Interactions between Alpha Interferon and Ribavirin against Bovine Viral Diarrhea Virus and Yellow Fever Virus as Surrogate Models of Hepatitis C Virus Replication"],"prefix":"10.1128","volume":"47","author":[{"given":"Victor E.","family":"Buckwold","sequence":"first","affiliation":[{"name":"Infectious Disease Research Department, Southern Research Institute, Frederick, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayi","family":"Wei","sequence":"additional","affiliation":[{"name":"Infectious Disease Research Department, Southern Research Institute, Frederick, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Wenzel-Mathers","sequence":"additional","affiliation":[{"name":"Infectious Disease Research Department, Southern Research Institute, Frederick, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Russell","sequence":"additional","affiliation":[{"name":"Infectious Disease Research Department, Southern Research Institute, Frederick, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.140220397"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-3542(01)00164-4"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","unstructured":"Blight K. J. A. Grakoui H. L. Hanson and C. M. Rice. 2002. The molecular biology of hepatitis C virus p. 81-108. In J.-H. J. Ou (ed.) Hepatitis viruses. Kluwer Academic Publishers Norwell Mass.","DOI":"10.1007\/978-1-4615-0881-6_4"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510260231"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.16.8189-8199.2002"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.21.11148-11154.2002"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.17.8505-8517.2002"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.111085598"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/82191"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-123-12-199512150-00001"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(96)80225-X"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-82-4-723"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2000.16661"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.2002.1487"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.18.8516-8523.2001"},{"key":"e_1_3_2_17_2","first-page":"827","volume":"162","year":"2000","unstructured":"Gutfreund, K. S., and V. C. Bain. 2000. Chronic viral hepatitis C: management update. Can. Med. Assoc. J.162:827-833.","journal-title":"Can. Med. Assoc. J."},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","unstructured":"Hamatake R. K. Z. Hong J. Y. N. Lau and W. Zhong. Antiviral agents for hepatitis viruses p. 235-277. In J.-H. J. Ou (ed.) Hepatitis viruses. Kluwer Academic Publishers Norwell Mass.","DOI":"10.1007\/978-1-4615-0881-6_10"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.26.4.476"},{"key":"e_1_3_2_20_2","first-page":"227","volume":"36","year":"2002","unstructured":"Kim, W. R., R. S. Brown, Jr., N. A. Terrault, and H. El-Serag. 2002. Burden of liver disease in the United States: summary of a workshop. Hepatology36:227-242.","journal-title":"Hepatology"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1128\/AAC.24.3.353","volume":"24","unstructured":"Kirsi, J. J., J. A. North, P. A. McKernan, B. K. Murray, P. G. Canonico, J. W. Huggins, P. C. Srivastava, and R. K. Robbins. Broad-spectrum antiviral activity of 2-\u03b2-d-ribofuranosylselenazole-4-carboxamide, a new antiviral agent. Antimicrob. Agents Chemother.24:353-361.","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.17.8074-8081.2001"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.2.1092-1104.2003"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.1.124-129.2003"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.32672"},{"key":"e_1_3_2_26_2","unstructured":"Lindenbach B. D. and C. M. Rice. 2001. Flaviviridae: the viruses and their replication p. 991-1041. In D. M. Knipe P. M. Howley D. E. Griffin R. A. Lamb M. A. Martin and B. Roizman (ed.) Fields virology 4th ed. vol. 1. Lippincott Williams & Wilkins Philadelphia Pa."},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.285.5424.110"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C100349200"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.4.859-866.2000"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-3542(96)89697-5"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-3542(02)00075-X"},{"key":"e_1_3_2_32_2","unstructured":"Prichard M. N. K. R. Aseltine and C. Shipman Jr. 1993. MacSynergy II. Version 1.0. User's manual. University of Michigan Ann Arbor."},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-3542(90)90001-N"},{"key":"e_1_3_2_34_2","first-page":"9","volume":"1","year":"1996","unstructured":"Prichard, M. N., and C. Shipman, Jr. 1996. Analysis of combinations of antiviral drugs and design of effective multidrug therapies. Antivir. Ther.1:9-20.","journal-title":"Antivir. Ther."},{"key":"e_1_3_2_35_2","first-page":"507","volume":"62","year":"2002","unstructured":"Scott, L. J., and C. M. Perry. 2002. Interferon-\u03b1-2b plus ribavirin. A review of its use in the management of chronic hepatitis C. Drugs62:507-556.","journal-title":"A review of its use in the management of chronic hepatitis C. Drugs"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.1.481-488.2003"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.1.244-254.2003"},{"key":"e_1_3_2_38_2","first-page":"261","volume":"12","year":"2002","unstructured":"Tam, R. C., J. Y. N. Lau, and Z. Hong. 2002. Mechanisms of action of ribavirin in antiviral therapies. Antivir. Chem. Chemother.12:261-272.","journal-title":"Antivir. Chem. Chemother."},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1159\/000050085"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/81.8.577"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.75.7.3042"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.21.11878"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.47.7.2293-2298.2003","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.47.7.2293-2298.2003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T18:27:48Z","timestamp":1645468068000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.47.7.2293-2298.2003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2003,7]]}},"alternative-id":["10.1128\/AAC.47.7.2293-2298.2003"],"URL":"https:\/\/doi.org\/10.1128\/aac.47.7.2293-2298.2003","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,7]]},"assertion":[{"value":"2002-10-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-04-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-07-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}